Erschienen in:
01.10.2013 | Letter
Hydroxyethyl starch 130/0.4 or hypertonic saline solution to decrease inflammatory response in hemorrhagic shock?
verfasst von:
Pierre Esnault, Bertrand Prunet, Jean Cotte, Pierre-Julien Cungi, Audrey Alonso, Ambroise Montcriol
Erschienen in:
Critical Care
|
Ausgabe 5/2013
Einloggen, um Zugang zu erhalten
Excerpt
We read with great interest the study by Chen and colleagues highlighting interest in hydroxyethyl starch (HES) 130/0.4 in treatment after hemorrhagic shock to ameliorate oxidative stress and the inflammatory response in a rat model. Compared with HES 200/0.5 and succinylated gelatin, the authors showed that infusions of HES 130/0.4 significantly reduced malondialdehyde levels and myeloperoxidase activity and also inhibited about 50% of TNF-α production in the intestine [
1]. …